New Study Reveals Abortion Pill Harms 1 in 10 Women, Far Exceeding FDA Claims
A new study of over 865,000 women challenges the FDA’s safety claims about the abortion pill mifepristone, revealing a 10.93% rate of serious adverse events—22 times higher than previously reported clinical trials. Pro-life researchers and advocates are calling for a reinstatement of stricter safety protocols and a reevaluation of the drug’s approval.
Read more : New Study Reveals Abortion Pill Harms 1 in 10 Women, Far Exceeding FDA Claims
